表紙
市場調查報告書
商品編碼
1029346

全球面部注射市場:行業趨勢、市場份額、市場規模、增長、機會、預測(2021-2026)

Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球面部注射市場預計將在 2021 年至 2026 年間以約 11% 的複合年增長率增長。

隨著年齡的增長,膠原蛋白的產生和皮下脂肪的形成減少,使皮膚更容易出現皺紋和下垂。這一點,再加上不斷增長的老年人口和保持年輕和健康皮膚的願望,是推動市場增長的關鍵因素之一。

對微創手術的需求增加以及醫療和美容旅遊的增加也促進了市場的增長。此外,過度曬傷會導致皮膚組織破壞,這增加了外出人士對面部注射的需求。此外,可支配收入的增加、社交媒體影響力的增加以及想要嘗試有機和可生物降解材料的專業從業者和用戶的增加也對市場產生了積極影響。

本報告調查了全球面部注射市場,並提供了全面的信息,包括市場概況、市場分析、價格分析、競爭格局和企業概況。

目錄

第一章前言

第二章範圍和調查方法

第 3 章執行摘要

第 4 章介紹

第 5 章全球面部注射市場

  • 市場概覽
  • 市場表現
  • COVID-19 的影響

第 6 章市場細分:按產品類型

  • 膠原蛋白
  • 透明質酸 (HA)
  • A 型肉毒桿菌毒素
  • 羥基磷灰石鈣 (CaHA)
  • 聚甲基丙烯酸甲酯珠粒(PMMA 微球)
  • 聚-L-乳酸 (PLLA)
  • 其他

第 7 章市場細分:按應用程序類型

  • 美容
  • 治療

第 8 章市場細分:按應用

  • 面部線條矯正
  • 唇部整形
  • 面部提升
  • 痤瘡疤痕治療
  • 其他

第 9 章市場細分:按最終用戶

  • 醫院
  • 皮膚科診所
  • 其他

第 10 章市場細分:按地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場細分:按國家/地區

第11章SWOT分析

第十二章價值鏈分析

第十三章波特五力分析

第14章價格分析

第15章競爭形勢

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Allergan Plc
    • Anika Therapeutics Inc.
    • Bloomage BioTechnology
    • Johnson & Johnson
    • Galderma Pharma S.A.
    • Integra LifeSciences
    • Ipsen(Mayroy SA)
    • Medytox Inc.
    • Merz Holding GmbH & Co. KG
    • Prollenium Medical Technologies Inc.
    • Sanofi
    • SciVision Biotech Inc.
    • Sinclair Pharma(Huadong Medicine Co. Ltd.)
    • Suneva Medical Inc.
    • Bausch Health Companies Inc
目錄
Product Code: SR1020F296_Report

The global facial injectables market is expected to grow at a CAGR of around 11% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise depressed scars. Currently, facial injectables are gaining traction worldwide as they are safe, cost-effective and require minimal downtime.

As collagen production and formation of fat under the skin decline with age, the skin becomes more susceptible to wrinkles and sagging. This, in confluence with the growing geriatric population and the desire to retain a young and healthy skin, represents one of the key factors bolstering the market growth. Apart from this, the escalating demand for minimally invasive surgeries, coupled with the rising trend of medical and cosmetic tourism, is contributing to the market growth. Moreover, as excessive sun exposure leads to tissue breakdown of the skin, the demand for facial injectables is escalating among outgoing individuals. Furthermore, inflating disposable incomes, the rising influence of social media, and the growing number of professional practitioners and users willing to try organic and biodegradable materials are some of the other factors influencing the market positively. Besides this, the key players are also offering customized facial injectables to provide a personalized experience to users, which, in turn, is anticipated to create a positive outlook for the market in the coming years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global facial injectables market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, application type, application and end user.

Breakup by Product Type:

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymethylmethacrylate Beads (PMMA Microspheres)
  • Poly-L-Lactic Acid (PLLA)
  • Others

Breakup by Application Type:

  • Aesthetics
  • Therapeutics

Breakup by Application:

  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Others

Breakup by End User:

  • Hospitals
  • Dermatology Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.1 Key Industry Trends

5 Global Facial Injectables Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Collagen
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hyaluronic Acid (HA)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Botulinum Toxin Type A
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Calcium Hydroxylapatite (CaHA)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Polymethylmethacrylate Beads (PMMA Microspheres)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Poly-L-Lactic Acid (PLLA)
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Application Type

  • 7.1 Aesthetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Therapeutics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Facial Line Correction
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lip Augmentation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Face Lift
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Acne Scar Treatment
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Dermatology Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Bloomage BioTechnology
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Galderma Pharma S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Integra LifeSciences
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Ipsen (Mayroy SA)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Medytox Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Merz Holding GmbH & Co. KG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Prollenium Medical Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 SciVision Biotech Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
    • 15.3.14 Suneva Medical Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
    • 15.3.15 Bausch Health Companies Inc
      • 15.3.15.1 Company Overview
      • 15.3.15.2 Product Portfolio
      • 15.3.15.3 Financials
      • 15.3.15.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Facial Injectables Market: Major Drivers and Challenges
  • Figure 2: Global: Facial Injectables Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Facial Injectables Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 4: Global: Facial Injectables Market: Breakup by Product Type (in %), 2020
  • Figure 5: Global: Facial Injectables Market: Breakup by Application Type (in %), 2020
  • Figure 6: Global: Facial Injectables Market: Breakup by Application (in %), 2020
  • Figure 7: Global: Facial Injectables Market: Breakup by End User (in %), 2020
  • Figure 8: Global: Facial Injectables Market: Breakup by Region (in %), 2020
  • Figure 9: Global: Facial Injectables (Collagen) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Facial Injectables (Collagen) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Facial Injectables (Hyaluronic Acid) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Facial Injectables (Hyaluronic Acid) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Facial Injectables (Botulinum Toxin Type A) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Facial Injectables (Botulinum Toxin Type A) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Facial Injectables (Calcium Hydroxylapatite) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Facial Injectables (Calcium Hydroxylapatite) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Facial Injectables (Polymethylmethacrylate Beads) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Facial Injectables (Polymethylmethacrylate Beads) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Facial Injectables (Poly-L-Lactic Acid) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Facial Injectables (Poly-L-Lactic Acid) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Facial Injectables (Other Product Types) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Facial Injectables (Other Product Types) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Facial Injectables (Aesthetics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Facial Injectables (Aesthetics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Facial Injectables (Therapeutics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Facial Injectables (Therapeutics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Facial Injectables (Facial Line Correction) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Facial Injectables (Facial Line Correction) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Facial Injectables (Lip Augmentation) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Facial Injectables (Lip Augmentation) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Facial Injectables (Face Lift) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Facial Injectables (Face Lift) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Facial Injectables (Acne Scar Treatment) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Facial Injectables (Acne Scar Treatment) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Facial Injectables (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Facial Injectables (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Global: Facial Injectables (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Global: Facial Injectables (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Global: Facial Injectables (Dermatology Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Global: Facial Injectables (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Global: Facial Injectables (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Global: Facial Injectables (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: North America: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: North America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: United States: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: United States: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Canada: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: Canada: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: Asia-Pacific: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: Asia-Pacific: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: China: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: China: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Japan: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Japan: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: India: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: India: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: South Korea: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: South Korea: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Australia: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Australia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Indonesia: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Indonesia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 63: Others: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 64: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 65: Europe: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 66: Europe: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 67: Germany: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 68: Germany: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 69: France: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 70: France: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 71: United Kingdom: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 72: United Kingdom: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 73: Italy: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 74: Italy: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 75: Spain: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 76: Spain: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 77: Russia: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 78: Russia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 79: Others: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 80: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 81: Latin America: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 82: Latin America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 83: Brazil: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 84: Brazil: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 85: Mexico: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 86: Mexico: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 87: Others: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 88: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 89: Middle East and Africa: Facial Injectables Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 90: Middle East and Africa: Facial Injectables Market: Breakup by Country (in %), 2020
  • Figure 91: Middle East and Africa: Facial Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 92: Global: Facial Injectables Industry: SWOT Analysis
  • Figure 93: Global: Facial Injectables Industry: Value Chain Analysis
  • Figure 94: Global: Facial Injectables Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Facial Injectables Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Facial Injectables Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
  • Table 3: Global: Facial Injectables Market Forecast: Breakup by Application Type (in Million US$), 2021-2026
  • Table 4: Global: Facial Injectables Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 5: Global: Facial Injectables Market Forecast: Breakup by End User (in Million US$), 2021-2026
  • Table 6: Global: Facial Injectables Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Facial Injectables Market Structure
  • Table 8: Global: Facial Injectables Market: Key Players